LENZ Therapeutics (LENZ) Shares Issued (2021 - 2026)
LENZ Therapeutics (LENZ) reported Shares Issued of $14000.0 for Q1 2026, down 68.18% year-over-year from $44000.0 in Q1 2025, and down 60.0% quarter-over-quarter from $35000.0 in Q4 2025.
LENZ Therapeutics (LENZ) Shares Issued (2021 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 6 years of Shares Issued data on file, last reported at $14000.0 in Q1 2026.
- Shares Issued for Q1 2026 came in at $14000.0, down 68.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.7 million (up 154.25% YoY), and the FY2025 annual result was $873000.0, down 78.38% from the prior year.
- Shares Issued fell to $14000.0 in Q1 2026 per LENZ's latest filing, from $35000.0 in the prior quarter.
- Over five years, Shares Issued peaked at $53.4 million in Q1 2024 and troughed at -$49.5 million in Q2 2024.
- A 5-year average of $2.2 million and a median of $97500.0 in 2024 frame the typical range for Shares Issued.
- On a YoY basis, Shares Issued climbed as much as 26199.01% in 2024 and fell as far as 24305.91% in 2024.
- A 5-year view of Shares Issued shows it stood at $242000.0 in 2022, then tumbled by 183.88% to -$203000.0 in 2023, then jumped by 167.98% to $138000.0 in 2024, then sank by 74.64% to $35000.0 in 2025, then sank by 60.0% to $14000.0 in 2026.
- Business Quant data shows LENZ's Shares Issued at $14000.0 in Q1 2026, $35000.0 in Q4 2025, and $598000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26,927.15 |
| 10 | LENZ Therapeutics | 192.19 Mn | 192.19 Mn | 825,000.00 | 14,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,000.00 |
| Mar 31, 2026 | 14,000.00 |
| Dec 31, 2025 | 35,000.00 |
| Dec 31, 2025 | 35,000.00 |
| Sep 30, 2025 | 598,000.00 |
| Sep 30, 2025 | 598,000.00 |
| Jun 30, 2025 | 26.10 Mn |
| Jun 30, 2025 | 26.10 Mn |
| Mar 31, 2025 | 44,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | -49.54 Mn |
| Jun 30, 2024 | -49.54 Mn |
| Mar 31, 2024 | 53.39 Mn |
| Mar 31, 2024 | 53.39 Mn |
| Dec 31, 2023 | -203,000.00 |
| Dec 31, 2023 | -203,000.00 |